Literature DB >> 18438699

Electrophysiological predictors of steroid-responsiveness in chronic inflammatory demyelinating polyneuropathy.

Y A Rajabally, M Narasimhan, G Chavada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18438699     DOI： 10.1007/s00415-008-0687-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Pure motor chronic inflammatory demyelinating polyneuropathy.

Authors:  M Sabatelli; F Madia; T Mignogna; G Lippi; L Quaranta; P Tonali
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

2.  Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.

Authors:  Pariwat Thaisetthawatkul; Eric L Logigian; David N Herrmann
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

3.  Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.

Authors:  A Sghirlanzoni; A Solari; C Ciano; C Mariotti; E Fallica; D Pareyson
Journal:  Neurol Sci       Date:  2000-02       Impact factor: 3.307

Review 4.  Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

5.  Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases.

Authors:  Yusuf A Rajabally; Saiju Jacob; Majed Hbahbih
Journal:  J Peripher Nerv Syst       Date:  2005-09       Impact factor: 3.494

6.  Abnormal sensory nerve conduction in multifocal demyelinating neuropathy with persistent conduction block.

Authors:  J Valls-Solé; A Cruz Martinez; F Graus; A Saiz; J Arpa; J M Grau
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

7.  Chronic inflammatory demyelinating polyradiculoneuropathy: features and prognostic factors with corticosteroid therapy.

Authors:  E Wertman; Z Argov; O Abrmasky
Journal:  Eur Neurol       Date:  1988       Impact factor: 1.710

8.  Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  R Hughes; S Bensa; H Willison; P Van den Bergh; G Comi; I Illa; E Nobile-Orazio; P van Doorn; M Dalakas; M Bojar; A Swan
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

9.  Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.

Authors:  Paul Magda; Norman Latov; Thomas H Brannagan; Louis H Weimer; Russell L Chin; Howard W Sander
Journal:  Arch Neurol       Date:  2003-12

10.  Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.

Authors:  M Donaghy; K R Mills; S J Boniface; J Simmons; I Wright; N Gregson; J Jacobs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154
View more
  2 in total

Review 1.  Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard Ac Hughes; Man Mohan Mehndiratta; Yusuf A Rajabally
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

2.  Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern.

Authors:  Filip Eftimov; Marinus H Liesdek; Camillus Verhamme; Ivo N van Schaik
Journal:  BMC Neurol       Date:  2014-04-04       Impact factor: 2.474
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.